INVESTABOT
Equity Research
XNAS · PHARMACEUTICAL PREPARATIONS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-07-02. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-05-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-06-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-06-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-06-18. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-06-05. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-06-01. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-05-29. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 1 Form 144 pre-sale notice filed on 2026-05-12. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least …
Vertex Pharmaceuticals (VRTX) had 2 Form 144 pre-sale notices filed on 2026-05-15. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least…
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 7/21/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | GRANT | 8,251 | — | — |
| 7/21/2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | GRANT | 8,251 | — | — |
| 7/15/2026 | SACHS BRUCE I | — | GRANT | 99.94 | $475 | $47,500 |
| 7/15/2026 | Garber Alan M | — | GRANT | 31.56 | $475 | $15,000 |
| 7/2/2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | SELL | -1,500 | $525 | $787,485 |
| 7/2/2026 | McKechnie Duncan | EVP, Chief Commercial Officer | SELL | -1,541 | $519 | $799,779 |
| 7/1/2026 | Liu Joy | EVP and Chief Legal Officer | SELL | -828 | $503 | $416,244 |
| 6/26/2026 | Bozic Carmen | EVP and CMO | SELL | -596 | $483 | $287,570 |
| 6/18/2026 | Bozic Carmen | EVP and CMO | SELL | -1,020 | $462 | $471,413 |
| 6/15/2026 | Bozic Carmen | EVP and CMO | SELL | -4,062 | $450 | $1,827,900 |
| 6/5/2026 | Bozic Carmen | EVP and CMO | SELL | -1,745 | $450 | $785,250 |
| 6/1/2026 | Liu Joy | EVP and Chief Legal Officer | SELL | -828 | $440 | $364,245 |
| 5/29/2026 | Bozic Carmen | EVP and CMO | SELL | -1,974 | $450 | $888,300 |
| 5/15/2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | SELL | -33 | $453 | $14,964 |
| 5/15/2026 | Bozic Carmen | EVP and CMO | SELL | -1,354 | $453 | $613,971 |
| 5/12/2026 | Bozic Carmen | EVP and CMO | SELL | -6,988 | $450 | $3,144,600 |
| 5/4/2026 | Bhatia Sangeeta N. | — | SELL | -318 | $424 | $134,746 |
| 5/1/2026 | Upadhyay Suketu | — | DISPOSITION | -796 | — | — |
| 5/1/2026 | Upadhyay Suketu | — | GRANT | 2,866 | — | — |
| 5/1/2026 | Upadhyay Suketu | — | GRANT | 796 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| 7/2/2026 | Tatsis Ourania | — | 1,500 | SEC |
| 7/2/2026 | McKechnie Duncan | — | 1,541 | SEC |
| 7/1/2026 | Liu Joy | — | 828 | SEC |
| 6/26/2026 | Bozic Carmen | — | 596 | SEC |
| 6/18/2026 | Bozic Carmen | — | 1,020 | SEC |
| 6/15/2026 | Bozic Carmen | — | 4,062 | SEC |
| 6/5/2026 | Bozic Carmen | — | 1,745 | SEC |
| 6/1/2026 | Liu Joy | — | 828 | SEC |
| 5/29/2026 | Bozic Carmen | — | 1,974 | SEC |
| 5/15/2026 | Bunnage Mark E. | — | 33 | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 24,109,373 | $11,975,848,722 | 0.6% | 8/7/2026 |
| Vanguard Group | 24,105,823 | $10,928,615,915 | — | 1/29/2026 |
| BlackRock | 23,751,989 | $10,768,201,653 | — | 2/12/2026 |
| BlackRock | 23,969,517 | $10,703,348,322 | 0.9% | 5/13/2026 |
| BlackRock | 21,312,244 | $9,989,475,160 | — | 8/13/2024 |
| State Street | 11,871,459 | $5,896,909,829 | 1.2% | 8/7/2026 |
| State Street | 11,689,539 | $5,299,569,401 | — | 2/13/2026 |
| State Street | 11,730,139 | $5,237,976,269 | 0.3% | 5/15/2026 |
| JP Morgan Chase | 6,674,600 | $3,334,964,973 | -7.5% | 8/12/2026 |
| JP Morgan Chase | 7,219,956 | $3,199,596,277 | 17.6% | 5/13/2026 |
| JP Morgan Chase | 6,141,281 | $2,784,211,285 | — | 2/11/2026 |
| Morgan Stanley | 3,242,139 | $1,610,469,452 | 1.7% | 8/13/2026 |
| Morgan Stanley | 3,188,881 | $1,423,964,743 | 2.2% | 5/15/2026 |
| Morgan Stanley | 3,120,310 | $1,414,625,263 | — | 5/27/2026 |
| Goldman Sachs | 2,531,961 | $1,257,700,855 | 2.6% | 8/14/2026 |
| Goldman Sachs | 2,466,575 | $1,101,424,226 | 36.1% | 5/15/2026 |
| Fidelity (FMR) | 2,212,596 | $1,003,101,845 | — | 2/17/2026 |
| Fidelity (FMR) | 2,020,265 | $902,128,614 | -8.7% | 5/15/2026 |
| Goldman Sachs | 1,812,218 | $821,587,288 | — | 3/25/2026 |
| Fidelity (FMR) | 1,457,158 | $723,814,230 | -27.9% | 8/13/2026 |